At a glance
ClinicalIndex Comparison RecordN/ACompleted· 500 target
Drug / intervention
Individualized BP loweringprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center Randomised Controlled Trial to Explore the Ideal Individualized Anti-hypertension Strategies in Patients With Severe Stroke at Acute Stage
In Brief
A clinical study evaluating Individualized BP lowering for Severe Stroke and 2 related conditions. Completed, enrolled 500 participants across 26 sites.
Detailed Summary
The purpose of this academic lead study is to explore ideal blood pressure targets and optimum individualized anti-hypertension strategies in acute severe stroke.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Stroke, Acute Stroke, Hypertension
CountriesChina
CollaboratorsTang-Du Hospital, Xi'an Central Hospital, Shaanxi Provincial People's Hospital, Hanzhong Central Hospital, Yan'an University Affiliated Hospital, Xiangyang Central Hospital, Xi'an 141 Hospital, Shangluo Central Hospital, 215 Hospital of Shaanxi NI, Yulin No.2 Hospital, Yulin No.1 Hospital, Ankang Central Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xi'an Gaoxin Hospital, 521 Hospital of NORINCO Group, Xi'an No.3 Hospital, Xi'an No.4 Hospital, Xi'an No.9 Hospital, Xi'an XD Group Hospital, Xi'an Traditional Chinese Medicine Hospital, Baoji Central Hospital, Weinan Central Hospital, Tongchuan Mining Hospital, Tongchuan People's Hospital
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartJan 2017
Primary CompletionNov 2018
TodayJul 2026
First PostedDec 5, 2016
Enrollment StartJan 1, 2017
Primary CompletionNov 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.6 years ago
Interventions
Individualized BP loweringprocedure